Brochure | May 12, 2021

Enabling Technology Platform: Patient-Centric Therapeutics

Source: Celanese
iStock-1208824917-molecule-structure

VitalDose® EVA is a copolymer drug-delivery platform providing controlled release through implant and insert dosage forms. Whether the challenge relates to a new molecular entity and new target, or an opportunity in the life cycle management, our scientists and engineers will partner with you to create novel drug-products.

  • Biologics and small molecules
  • High drug loading capacity
  • Variety of geometries
  • Local or systemic administration
  • Long clinical use history
  • Established regulatory path
VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: